Get Started
Multiple Sclerosis Curricula
Step 1
These independent CME/CE activities are supported by educational grants from Celgene Corporation, Novartis Pharmaceuticals Corporation, and
Sanofi Genzyme.

State of the                        Multiple Sclerosis
Science                              Innovations
  1. Course List
Search by

Currently Available

Course Title Faculty Release Date
MS Innovations: RRMS Patient Worsens and Receives a New Diagnosis of SPMSCase Study (1) 2336.14 Coyle Oct 2018
MS Innovations: Management of an RRMS Patient With Breakthrough DiseaseCase Study (2) 2336.15 Bowen Oct 2018
Practical Analysis of: Siponimod Versus Placebo in Secondary Progressive Multiple Sclerosis (EXPAND): a Double-Blind, Randomised, Phase 3 StudyPractical Analysis (3) 2336.04 Rinker Sep 2018
Practical Analysis of: Practice Guideline Recommendations Summary: Disease-Modifying Therapies for Adults with Multiple Sclerosis. Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyPractical Analysis (4) 2336.05 Cross Sep 2018
Practical Analysis of: No Evidence of Disease Activity in Patients Receiving Fingolimod at Private or Academic Centers in Clinical Practice: a Retrospective Analysis of The Multiple Sclerosis, Clinical, and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) StudyPractical Analysis (5) 2336.06 Bowen Sep 2018
Advances and Innovations in Managing Multiple Sclerosis: Meeting Coverage UpdateWebcast (6) 2336.23 Perrin Ross
Sep 2018
Key Topics in MS: A Video WebcastWebcast (7) 2336.22 Bowen
Aug 2018
RRMS Patient With Preference for Oral MedicationsCase Study (8) 2336.13 Rinker Jul 2018
Practical Analysis of: Cardiac Safety of Ozanimod, a Novel Sphingosine-1-Phosphate Receptor Modulator: Results of a Thorough QT/QTc StudyPractical Analysis (9) 2336.02 Bowen May 2018
Practical Analysis of: Patient-Reported Outcomes in Relapsing Forms of MS: Real-World, Global Treatment Experience With Teriflunomide From the Teri-PRO StudyPractical Analysis (10) 2336.03 Rinker May 2018
Managing a Relapsing MS Patient With Active DiseaseCase Study (11) 2336.12 Chahin May 2018
Key Topics in MS from Recent Meetings: An Audio WebcastWebcast (12) 2336.21 Cross
Mar 2018
Treatment of a Relapsing Multiple Sclerosis Patient Requiring a Therapy SwitchCase Study (13) 2336.11 Cross Feb 2018
Practical Analysis of: CARE-MS II 5-Year Follow-Up, Including 3-Year Open-Label Extension: Efficacy and Safety FindingsPractical Analysis (14) 2336.01 Cross Nov 2017